의료용 챗봇 및 가상 비서 시장 예측(-2034년) : 유형, 도입 형태, 기술, 용도, 최종사용자 및 지역별 세계 분석

According to Stratistics MRC, the Global Healthcare Chatbots & Virtual Assistants Market is accounted for $1.2 billion in 2026 and is expected to reach $12 billion by 2034 growing at a CAGR of 33% during the forecast period. Healthcare Chatbots & Virtual Assistants are AI-powered digital tools designed to interact with patients and healthcare providers through text or voice interfaces. They assist with tasks such as symptom checking, appointment scheduling, medication reminders, and patient education. These tools improve accessibility, reduce administrative workload, and enhance patient engagement. Advanced systems use natural language processing and machine learning to provide personalized responses. As digital health adoption grows, chatbots and virtual assistants are becoming essential for delivering scalable, efficient, and patient-centric healthcare services.

Market Dynamics:

Driver:

Rising adoption of AI in healthcare

AI-powered solutions enable real-time patient engagement, symptom checking, appointment scheduling, and medication reminders, reducing the burden on healthcare staff. Hospitals and clinics are increasingly deploying these tools to streamline workflows and improve patient satisfaction. AI integration also enhances personalization, allowing chatbots to provide tailored recommendations based on patient history and preferences. The technology supports multilingual communication, expanding accessibility across diverse populations. As AI algorithms become more sophisticated, their ability to handle complex queries and integrate with electronic health records is improving.

Restraint:

Data privacy and security challenges

Healthcare chatbots and virtual assistant systems handle sensitive patient information, making them vulnerable to breaches and unauthorized access. Compliance with regulations such as HIPAA and GDPR adds complexity to deployment, particularly across multiple jurisdictions. Healthcare providers are cautious about adopting solutions that may expose them to legal risks or reputational damage. Patients themselves are increasingly concerned about how their data is stored and used, which can affect trust and adoption rates. Vendors are investing in encryption, secure cloud infrastructure, and advanced authentication protocols to mitigate these risks.

Opportunity:

Integration with telehealth platforms

Telehealth adoption surges globally, chatbots can serve as the first point of contact for patients, triaging cases and directing them to appropriate care channels. Virtual assistants can also support video consultations by managing scheduling, reminders, and follow-up interactions. This integration enhances efficiency, reduces wait times, and improves patient satisfaction. Telehealth providers benefit from reduced administrative overhead, while patients gain seamless access to care. The combination of chatbots and telehealth platforms also supports chronic disease management and remote monitoring.

Threat:

Lack of trust among patients

Many patients remain skeptical about relying on automated systems for medical advice or support. Concerns include accuracy of information, empathy in communication, and the ability of chatbots to handle complex health issues. In some cases, patients prefer direct interaction with human providers, fearing that chatbots may overlook critical symptoms. This skepticism can limit adoption, particularly among older populations or those with limited digital literacy. Building trust requires transparent communication, clinical validation, and integration with trusted healthcare providers.

Covid-19 Impact:

The COVID-19 pandemic significantly accelerated the adoption of healthcare chatbots and virtual assistants. With hospitals overwhelmed and physical consultations restricted, chatbots became essential for triaging patients, providing symptom checks, and disseminating reliable information. Virtual assistants supported appointment scheduling, vaccination reminders, and remote monitoring, reducing strain on healthcare staff. Governments and healthcare organizations invested heavily in digital health infrastructure during this period, creating lasting momentum for chatbot adoption. The pandemic also highlighted the importance of scalable, AI-driven communication tools in crisis management.

The appointment scheduling segment is expected to be the largest during the forecast period

The appointment scheduling segment is expected to account for the largest market share during the forecast period as the rising adoption of AI in healthcare has streamlined scheduling workflows and reduced administrative burdens. Chatbots and virtual assistants can manage patient bookings, send reminders, and reschedule appointments with minimal human intervention. This automation improves efficiency for healthcare providers and enhances convenience for patients. Integration with electronic health records ensures accurate scheduling and reduces errors. The segment also benefits from growing demand for telehealth services, where digital scheduling is critical. Hospitals and clinics are increasingly adopting AI-driven scheduling tools to optimize resource utilization.

The patients segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the patients segment is predicted to witness the highest growth rate due to the rising adoption of AI in healthcare, which enables personalized and accessible patient engagement. Chatbots provide 24/7 support, answering queries, offering symptom checks, and guiding patients through treatment pathways. Virtual assistants improve adherence by sending medication reminders and lifestyle recommendations. Patients benefit from reduced wait times and immediate access to information, enhancing satisfaction and trust. The segment is also driven by increasing smartphone penetration and digital literacy among patients.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share owing to advanced healthcare infrastructure and the rising adoption of AI in healthcare across hospitals and clinics. The U.S. has seen widespread deployment of chatbots for appointment scheduling, patient engagement, and chronic disease management. Favorable reimbursement policies and strong regulatory frameworks support adoption. The presence of leading technology vendors and healthcare providers further strengthens the region's position. High prevalence of chronic diseases and aging populations drive demand for continuous patient support. North America's dominance is expected to persist, supported by ongoing innovation and investment in AI-driven healthcare solutions.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR driven by rapid healthcare digitization and the rising adoption of AI in healthcare across emerging economies. Countries such as India, China, and Southeast Asia are actively deploying chatbots to address healthcare access gaps. Governments are promoting telehealth and digital health initiatives to improve equity and reduce costs. Increasing smartphone penetration and mobile connectivity enhance the feasibility of chatbot adoption. Local startups and global players are collaborating to deliver cost-effective, multilingual solutions tailored to regional needs. As awareness and acceptance grow, Asia Pacific is poised to become the fastest-growing market for healthcare chatbots and virtual assistants.

Key players in the market

Some of the key players in Healthcare Chatbots & Virtual Assistants Market include Microsoft Corporation, IBM Corporation, Google LLC, Amazon Web Services Inc., Nuance Communications, Babylon Health, Ada Health GmbH, Buoy Health Inc., Sensely Inc., HealthTap Inc., Kore.ai, Orbita Inc., GYANT Inc., Infermedica, Wysa Ltd. and CareAngel.

Key Developments:

In March 2026, Microsoft launched Copilot Health, an AI-driven assistant integrated into its Copilot platform. The tool aggregates medical records, wearable data, and health history to deliver personalized health insights. Positioned as a secure, encrypted portal, Copilot Health aims to enhance patient engagement and clinical guidance, competing directly with Google and Amazon in healthcare-focused conversational AI.

In July 2025, IBM Research advanced its healthcare AI portfolio by deploying foundation models for clinical data interpretation. These models support radiotherapy education chatbots and predictive analytics for neurology. IBM's healthcare AI initiatives emphasize biomarker discovery, drug development acceleration, and clinician support, leveraging quantum computing partnerships with Cleveland Clinic to integrate conversational AI into research and patient-facing applications.

In February 2025, Google unveiled Med-PaLM 2, a medical AI chatbot built on PaLM 2, designed to handle complex healthcare queries. Med-PaLM 2 enhances patient-doctor interactions, particularly in underserved regions, by providing accurate medical insights.

Types Covered:

• Rule-Based Chatbots
• AI-Powered Conversational Assistants
• Voice Assistants
• Hybrid Chatbots
• Other Types

Deployment Modes Covered:

• Cloud-Based
• On-Premises

Technologies Covered:

• Natural Language Processing (NLP)
• Machine Learning
• Speech Recognition
• Context-Aware AI
• Other Technologies

Applications Covered:

• Symptom Checking & Triage
• Appointment Scheduling
• Medication Assistance
• Mental Health Support
• Patient Engagement & Monitoring
• Other Applications

End Users Covered:

• Healthcare Providers
• Patients
• Payers & Insurance Companies
• Pharmaceutical Companies
• Other End Users

Regions Covered:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Belgium
  • Sweden
  • Switzerland
  • Poland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Vietnam
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Rest of South America
• Rest of the World (RoW)
  • Middle East
• Saudi Arabia
• United Arab Emirates
• Qatar
• Israel
• Rest of Middle East
  • Africa
• South Africa
• Egypt
• Morocco
• Rest of Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

• 1.1 Market Snapshot and Key Highlights
• 1.2 Growth Drivers, Challenges, and Opportunities
• 1.3 Competitive Landscape Overview
• 1.4 Strategic Insights and Recommendations

2 Research Framework

• 2.1 Study Objectives and Scope
• 2.2 Stakeholder Analysis
• 2.3 Research Assumptions and Limitations
• 2.4 Research Methodology
  • 2.4.1 Data Collection (Primary and Secondary)
  • 2.4.2 Data Modeling and Estimation Techniques
  • 2.4.3 Data Validation and Triangulation
  • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

• 3.1 Market Definition and Structure
• 3.2 Key Market Drivers
• 3.3 Market Restraints and Challenges
• 3.4 Growth Opportunities and Investment Hotspots
• 3.5 Industry Threats and Risk Assessment
• 3.6 Technology and Innovation Landscape
• 3.7 Emerging and High-Growth Markets
• 3.8 Regulatory and Policy Environment
• 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

• 4.1 Porter's Five Forces Analysis
  • 4.1.1 Supplier Bargaining Power
  • 4.1.2 Buyer Bargaining Power
  • 4.1.3 Threat of Substitutes
  • 4.1.4 Threat of New Entrants
  • 4.1.5 Competitive Rivalry
• 4.2 Market Share Analysis of Key Players
• 4.3 Product Benchmarking and Performance Comparison

5 Global Healthcare Chatbots & Virtual Assistants Market, By Type

• 5.1 Rule-Based Chatbots
• 5.2 AI-Powered Conversational Assistants
• 5.3 Voice Assistants
• 5.4 Hybrid Chatbots
• 5.5 Other Types

6 Global Healthcare Chatbots & Virtual Assistants Market, By Deployment Mode

• 6.1 Cloud-Based
• 6.2 On-Premises

7 Global Healthcare Chatbots & Virtual Assistants Market, By Technology

• 7.1 Natural Language Processing (NLP)
• 7.2 Machine Learning
• 7.3 Speech Recognition
• 7.4 Context-Aware AI
• 7.5 Other Technologies

8 Global Healthcare Chatbots & Virtual Assistants Market, By Application

• 8.1 Symptom Checking & Triage
• 8.2 Appointment Scheduling
• 8.3 Medication Assistance
• 8.4 Mental Health Support
• 8.5 Patient Engagement & Monitoring
• 8.6 Other Applications

9 Global Healthcare Chatbots & Virtual Assistants Market, By End User

• 9.1 Healthcare Providers
• 9.2 Patients
• 9.3 Payers & Insurance Companies
• 9.4 Pharmaceutical Companies
• 9.5 Other End Users

10 Global Healthcare Chatbots & Virtual Assistants Market, By Geography

• 10.1 North America
  • 10.1.1 United States
  • 10.1.2 Canada
  • 10.1.3 Mexico
• 10.2 Europe
  • 10.2.1 United Kingdom
  • 10.2.2 Germany
  • 10.2.3 France
  • 10.2.4 Italy
  • 10.2.5 Spain
  • 10.2.6 Netherlands
  • 10.2.7 Belgium
  • 10.2.8 Sweden
  • 10.2.9 Switzerland
  • 10.2.10 Poland
  • 10.2.11 Rest of Europe
• 10.3 Asia Pacific
  • 10.3.1 China
  • 10.3.2 Japan
  • 10.3.3 India
  • 10.3.4 South Korea
  • 10.3.5 Australia
  • 10.3.6 Indonesia
  • 10.3.7 Thailand
  • 10.3.8 Malaysia
  • 10.3.9 Singapore
  • 10.3.10 Vietnam
  • 10.3.11 Rest of Asia Pacific
• 10.4 South America
  • 10.4.1 Brazil
  • 10.4.2 Argentina
  • 10.4.3 Colombia
  • 10.4.4 Chile
  • 10.4.5 Peru
  • 10.4.6 Rest of South America
• 10.5 Rest of the World (RoW)
  • 10.5.1 Middle East
    • 10.5.1.1 Saudi Arabia
    • 10.5.1.2 United Arab Emirates
    • 10.5.1.3 Qatar
    • 10.5.1.4 Israel
    • 10.5.1.5 Rest of Middle East
  • 10.5.2 Africa
    • 10.5.2.1 South Africa
    • 10.5.2.2 Egypt
    • 10.5.2.3 Morocco
    • 10.5.2.4 Rest of Africa

11 Strategic Market Intelligence

• 11.1 Industry Value Network and Supply Chain Assessment
• 11.2 White-Space and Opportunity Mapping
• 11.3 Product Evolution and Market Life Cycle Analysis
• 11.4 Channel, Distributor, and Go-to-Market Assessment

12 Industry Developments and Strategic Initiatives

• 12.1 Mergers and Acquisitions
• 12.2 Partnerships, Alliances, and Joint Ventures
• 12.3 New Product Launches and Certifications
• 12.4 Capacity Expansion and Investments
• 12.5 Other Strategic Initiatives

13 Company Profiles

• 13.1 Microsoft Corporation
• 13.2 IBM Corporation
• 13.3 Google LLC
• 13.4 Amazon Web Services Inc.
• 13.5 Nuance Communications
• 13.6 Babylon Health
• 13.7 Ada Health GmbH
• 13.8 Buoy Health Inc.
• 13.9 Sensely Inc.
• 13.10 HealthTap Inc.
• 13.11 Kore.ai
• 13.12 Orbita Inc.
• 13.13 GYANT Inc.
• 13.14 Infermedica
• 13.15 Wysa Ltd.
• 13.16 CareAngel